Sort
82,697 grants matching “vaccine development”
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$3,241,549Stephen A Spector · University Of California, San Diego · UM1 · FY2020 · AI
Oklahoma Shared Clinical and Translational Resources
$3,240,887Judith A James · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2020 · GM
Tuberculosis Research Unit
$3,240,332W. Henry Boom · Case Western Reserve University · N01 · FY2013 · AI
IP24-045, SEAPREP: Seattle Pandemic Preparedness Cohort
$3,239,804Helen Ying-Hui Chu · University Of Washington · U01 · FY2025 · IP
STAGED VACCINE DEVELOPMENT OF ADENIVIRUS-4 VECTORED VACCINE FOR HUMAN IMMUNODEFICIENCY VIRUS
$3,239,039Paul Shabram · Paxvax, Inc. · N01 · FY2016 · AI
Harvard University Center for AIDS Research
$3,238,711Bruce D Walker · Harvard University · P30 · FY2013 · AI
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$3,238,555Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2017 · AI
Intervention Trials in Persons at Increased Genetic Risk of Cancer
$3,238,292Mark H Greene · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
Tuberculosis Imaging Program
$3,238,062Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI
Cellular Immunity to Category A-C Viruses in Humans
$3,237,810Alan L Rothman · Univ Of Massachusetts Med Sch Worcester · U19 · FY2010 · AI
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
$3,236,867Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2012 · AI
Emory-CDC CTU
$3,234,078Colleen F Kelley · Emory University · UM1 · FY2025 · AI
Mechanisms of protective immunity induced by live attenuated SIV vaccines
$3,233,225R. Paul Johnson · Harvard Medical School · P01 · FY2011 · AI
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N
$3,233,217Laurence Lemiale · Emergent Product Development Gaithersbur · N01 · FY2015 · AI
MIDAS Center for Communicable Disease Dynamics
$3,231,697Marc Lipsitch · Harvard School Of Public Health · U54 · FY2009 · GM
CCR Genomics Core
$3,231,619Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Leveraging Longitudinal Survey and EHR data to Dissect the Impact of COVID-19 related Stressors and Infections on Child Mental Health and Suicide Risks
$3,231,590Yunyu Xiao · Weill Medical Coll Of Cornell Univ · RF1 · FY2023 · MH
Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases
$3,229,247Elizabeth Norton · Tulane University Of Louisiana · N01 · FY2025 · AI
Cellular Immunity to Category A-C Viruses in Humans
$3,228,322Francis Anthony Ennis · Univ Of Massachusetts Med Sch Worcester · U19 · FY2006 · AI
Assays to Support Development of Malaria Transmission Blocking Vaccines
$3,226,715Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Cellular Immunity to Category A-C Viruses in Humans
$3,226,577Francis Anthony Ennis · Univ Of Massachusetts Med Sch Worcester · U19 · FY2007 · AI
Cellular Immunity to Category A-C Viruses in Humans
$3,226,576Francis Anthony Ennis · Univ Of Massachusetts Med Sch Worcester · U19 · FY2008 · AI
Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU
$3,226,409Daniel R Kuritzkes · Massachusetts General Hospital · UM1 · FY2012 · AI
Nanomedicine Center for Nucleoprotein Machines
$3,224,999Gang Bao · Georgia Institute Of Technology · PN2 · FY2012 · EY
Nanomedicine Center for Nucleoprotein Machines
$3,224,999Gang Bao · Georgia Institute Of Technology · PN2 · FY2013 · EY